http://seekingalpha.com/article/1994961-biota-pharmaceuticals-inc-and-venaxis-inc-2-upcoming-biopharmaceuticals-catalysts-that-could-generate-big-gains?source=yahoo
"The company has a world-wide license from Daiichi Sankyo company, Ltd to develop and commercialize a number of LANIs, including laninamivir octanoate, which is marketed by Daiichi Sankyo as Invavir® in Japan."
It should be the other way around... A wrong perception by most US investors...
http://seekingalpha.com/article/1994961-biota-pharmaceuticals-inc...
Add to My Watchlist
What is My Watchlist?